Literature DB >> 6233529

Antibody to Pseudomonas aeruginosa mucoid exopolysaccharide and to sodium alginate in cystic fibrosis serum.

D P Speert, D Lawton, L M Mutharia.   

Abstract

Antibodies in cystic fibrosis (CF) sera to Pseudomonas aeruginosa mucoid exopolysaccharide and to sodium alginate (a polysaccharide from seaweed chemically similar to mucoid exopolysaccharide) were measured in sera of CF patients to determine if the exopolysaccharide is immunogenic. An enzyme-linked immunosorbent assay was used to test sera from 26 CF patients (18 colonized with pseudomonas and eight non-colonized) and 26 healthy controls. CF patients colonized with pseudomonas had more antibody to mucoid exopolysaccharide (P = 0.0008) and to sodium alginate (P = 0.0008) than did non-colonized CF patients. Virtually none was found in healthy controls. Duration of colonization was correlated with the level of antibody to sodium alginate (P = 0.003) but not with antibody to mucoid exopolysaccharide. Mucoid exopolysaccharide is immunogenic in patients with CF.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233529     DOI: 10.1203/00006450-198405000-00008

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  12 in total

1.  Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis.

Authors:  S S Pedersen; F Espersen; N Høiby; T Jensen
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

2.  Hypochlorite scavenging by Pseudomonas aeruginosa alginate.

Authors:  D B Learn; E P Brestel; S Seetharama
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

3.  Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.

Authors:  I Eichler; L Joris; Y P Hsu; J Van Wye; R Bram; R Moss
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

Review 4.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

5.  Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.

Authors:  S S Pedersen; N Høiby; F Espersen; C Koch
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

6.  Alginase treatment of mucoid Pseudomonas aeruginosa enhances phagocytosis by human monocyte-derived macrophages.

Authors:  F Eftekhar; D P Speert
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

7.  Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.

Authors:  G B Pier; S Takeda; M Grout; R B Markham
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

8.  Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide.

Authors:  P Ames; D DesJardins; G B Pier
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

9.  [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].

Authors:  U Winkler; J Wingender; K E Jäger
Journal:  Klin Wochenschr       Date:  1985-06-03

10.  Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis.

Authors:  S S Pedersen; F Espersen; N Høiby; G H Shand
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.